9-MTH group results (IFRS)
Feb 6 (Reuters)-
Mitsubishi Chemical Group Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2023 Dec 31, 2022 Mar 31, 2024
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 3.25 trln 3.41 trln 4.46 trln
(-4.7 pct) (+17.4 pct) (-3.9 pct)
Operating 212.50 48.62 295.00
(+337.0 pct) (-77.7 pct) (+61.5 pct)
Pretax 191.78 39.21 263.00
(+389.2 pct) (-81.2 pct) (+56.6 pct)
Net 103.86 17.04 135.00
(+509.6 pct) (-86.0 pct) (+40.0 pct)
EPS Basic 73.02 yen 11.99 yen 94.90 yen
EPS Diluted 69.88 yen 11.55 yen
Ann Div 30.00 yen 32.00 yen
-Q2 Div 16.00 yen 15.00 yen
-Q4 Div 15.00 yen 16.00 yen
NOTE - Mitsubishi Chemical Group Corporation.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)